Number of the records: 1
Therapeutic continuity in Alzheimer's disease: switching patients to Galantamine
SYS c027644 LBL ^^^^^nam^^22^^^^^^^^450^ 005 20020531143357.0 100 $a 20010807d m y0sloc0103 ba 101 0-
$a eng 102 $a US 105 $a a aozd000yy 200 1-
$a Therapeutic continuity in Alzheimer's disease: switching patients to Galantamine $f John C. Morris, guest editor 210 $a Hellsborough $c Excerpta Medica, a Reed Elsevier Medical Publishing Co. $d 2001 215 $a A40 s. 225 2-
$a Clinical Therapeutics $e the international peer-reviewed journal of drug therapy $v Suppl. A $x 0149-2918 541 1-
$a Terapeutická kontinuita pri Alzheimerovej chorobe: prechod pacientov na glantamine 606 1-
$a Alzheimerova choroba $x farmakoterapia $2 mesh $3 sllk_un_auth*d000544 $9 . 606 1-
$a galantamín $2 mesh $3 sllk_un_auth*d005702 $9 . 606 1-
$a inhibítory cholínesteráz $2 mesh $3 sllk_un_auth*d002800 $9 . 675 $a 616.892.32-085 $v 1. stred. $z slo 702 -1
$a Morris $b John C. $3 sllk_un_auth*p0027241 $4 340 $p Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA 801 -0
$a SK $b BA006 $c 20010807 $g AACR2
Number of the records: 1